PURPLE BIOTECH LTD. Logo

PURPLE BIOTECH LTD.

Develops first-in-class therapies targeting tumor immune evasion and drug resistance in cancer.

PPBT | US

Overview

Corporate Details

ISIN(s):
US74638P1093 (+1 more)
LEI:
Country:
United States of America
Address:
4 OPPENHEIMER STREET, 7670104 REHOVOT
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Purple Biotech Ltd. is a clinical-stage company developing first-in-class therapies designed to overcome tumor immune evasion and drug resistance. The company's core strategy involves harnessing the tumor microenvironment (TME) to develop effective and durable treatments. By focusing on novel therapeutic mechanisms, Purple Biotech aims to improve clinical outcomes for cancer patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all PURPLE BIOTECH LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PURPLE BIOTECH LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PURPLE BIOTECH LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
DYNAVAX TECHNOLOGIES CORP Logo
Biopharma firm developing novel vaccines, like its adult hepatitis B vaccine, with adjuvant tech.
United States of America DVAX
Dyne Therapeutics, Inc. Logo
Developing targeted therapies for genetic neuromuscular diseases via its FORCE™ platform.
United States of America DYN
Manufactures vet pharma for livestock/aquaculture & distributes premium pet food.
South Korea 044960
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom EAH
Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden ECTIN B
Edesa Biotech, Inc. Logo
Develops treatments for inflammatory and immune diseases like Acute Respiratory Distress Syndrome.
United States of America EDSA
Edgewise Therapeutics, Inc. Logo
Developing novel therapeutics for rare and serious muscle disorders.
United States of America EWTX
Editas Medicine, Inc. Logo
Developing CRISPR-based genomic medicines to treat serious and rare genetic diseases.
United States of America EDIT
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden EGTX

Talk to a Data Expert

Have a question? We'll get back to you promptly.